Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.8665
|
0.9075
|
0.815
|
0.815
|
0.9005
|
0.8865
|
|
|
|
|
0.7955
|
0.829
|
0.815
|
0.79
|
0.836
|
0.79
|
|
|
|
|
0.739
|
0.7735
|
0.759
|
0.737
|
0.765
|
0.746
|
|
|
|
|
0.743
|
0.7745
|
0.7605
|
0.749
|
0.7805
|
0.7575
|
|
|
|
|
0.742
|
0.7735
|
0.7135
|
0.7135
|
0.7695
|
0.7695
|
|
|
|
|
0.6975
|
0.7265
|
0.7575
|
0.7085
|
0.7805
|
0.7085
|
|
|
|
|
0.7465
|
0.7795
|
0.691
|
0.6875
|
0.7495
|
0.7495
|
|
|
|
|
0.677
|
0.7085
|
0.696
|
0.687
|
0.7015
|
0.6955
|
|
|
|
|
0.679
|
0.7105
|
0.6915
|
0.649
|
0.7085
|
0.7085
|
|
|
|
|
0.668
|
0.703
|
0.6945
|
0.68
|
0.711
|
0.68
|
|
|
|
|
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States.